Biomarker Identification for Oropharyngeal Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to find a specific biomarker (a biological indicator) for a type of throat cancer linked to the human papillomavirus (HPV). Researchers seek to identify this marker in individuals with HPV-related oropharyngeal cancer and confirm its absence in those without the cancer. Participants provide blood and saliva samples, complete questionnaires, and share medical records to support the study. Ideal participants have consented to provide samples and have a clinical suspicion or diagnosis of head and neck cancer, salivary, or thyroid neoplasm.
As an unphased trial, this study offers participants the chance to contribute to groundbreaking research that could lead to earlier detection and improved treatment options for HPV-related throat cancer.
Do I have to stop taking my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
Why are researchers excited about this trial?
Researchers are excited about this trial because it focuses on finding biomarkers for oropharynx conditions through non-invasive methods. Unlike traditional treatments that primarily involve surgery, radiation, or chemotherapy, this approach involves collecting blood and saliva samples, reviewing medical records, and completing questionnaires. The unique aspect of this method is its potential to identify specific biomarkers that could lead to earlier detection and more personalized treatment options, which might improve patient outcomes and reduce side effects compared to current treatment methods.
Who Is on the Research Team?
Kathryn M. Van Abel, MD
Principal Investigator
Mayo Clinic in Rochester
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Observational
Patients undergo blood sample collection, saliva sample collection, complete questionnaires and have their medical records reviewed
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Non-Interventional Study
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Patients undergo blood sample collection, saliva sample collection, complete questionnaires and have their medical records reviewed on study.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mayo Clinic
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.